FDA Clearance Tracker · K072913
SECURMARK BIOPSY SITE IDENTIFICATION SYSTEM
Last checked: Nov 19, 2026Latest source record: Jan 4, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Jan 4, 2008
Substantially Equivalent
Time to decision
84 days
Received Oct 12, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K072913
- Device name
- SECURMARK BIOPSY SITE IDENTIFICATION SYSTEM
- Applicant location
- Indianapolis, IN
- Received
- Oct 12, 2007
- Decided
- Jan 4, 2008
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Marker, Radiographic, Implantable (NEU)
- Device class
- Class II
- Regulation
- 21 CFR 878.4300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- We could not check whether this was the first decision under its product code.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K072913
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Suros Surgical Systems, Inc. A Hologic Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.